Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of BACIL PHARMA. For more details, see the BACIL PHARMA quarterly results and BACIL PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -2.0 |
No. of shares | m | 5.89 |
1 Week | % | 8.1 |
1 Month | % | 41.4 |
1 Year | % | 343.4 |
52 week H/L | Rs | 24.7/4.7 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
BACIL PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 4 | 2 | 6 | 10 | 10 | |
Low | Rs | 2 | 2 | 2 | 3 | 4 | |
Sales per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Earnings per share (Unadj.) | Rs | -0.6 | -0.5 | -0.4 | -6.6 | -0.2 | |
Diluted earnings per share | Rs | -0.6 | -0.5 | -0.4 | -6.6 | -0.2 | |
Cash flow per share (Unadj.) | Rs | -0.6 | -0.5 | -0.4 | -6.5 | -0.2 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 3.2 | 2.4 | 2.4 | 2.1 | 1.9 | |
Adj. book value per share | Rs | 3.2 | 2.4 | 2.4 | 2.1 | 1.9 | |
Shares outstanding (eoy) | m | 5.89 | 5.89 | 5.89 | 5.89 | 5.89 | |
Price / Sales ratio | x | 0 | 0 | 0 | 0 | 0 | |
Avg P/E ratio | x | -5.6 | -3.8 | -9.5 | -1.0 | -38.6 | |
P/CF ratio (eoy) | x | -5.7 | -3.9 | -9.7 | -1.0 | -39.6 | |
Price / Book Value ratio | x | 1.0 | 0.9 | 1.6 | 3.1 | 3.6 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 19 | 12 | 23 | 38 | 39 | |
Total wages/salary | Rs m | 1 | 1 | 1 | 1 | 1 |
BACIL PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 0 | 0 | 0 | 0 | 0 | |
Other income | Rs m | 1 | 1 | 1 | 1 | 1 | |
Total revenues | Rs m | 1 | 1 | 1 | 1 | 1 | |
Gross profit | Rs m | -4 | -4 | -3 | -39 | -2 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | -3 | -3 | -2 | -39 | -1 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | -3 | -3 | -2 | -39 | -1 | |
Gross profit margin | % | 0 | 0 | 0 | 0 | 0 | |
Effective tax rate | % | 0.3 | 0.1 | 0.2 | 0 | 0 | |
Net profit margin | % | 0 | 0 | 0 | 0 | 0 |
BACIL PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 6 | 3 | 3 | 3 | 2 | |
Current liabilities | Rs m | 26 | 27 | 27 | 0 | 0 | |
Net working cap to sales | % | 0 | 0 | 0 | 0 | 0 | |
Current ratio | x | 0.2 | 0.1 | 0.1 | 6.7 | 8.2 | |
Inventory Days | Days | 0 | 0 | 0 | 0 | 0 | |
Debtors Days | Days | 0 | 0 | 0 | 0 | 0 | |
Net fixed assets | Rs m | 39 | 36 | 37 | 8 | 8 | |
Share capital | Rs m | 65 | 65 | 65 | 65 | 65 | |
"Free" reserves | Rs m | -46 | -51 | -51 | -53 | -54 | |
Net worth | Rs m | 19 | 14 | 14 | 12 | 11 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 44 | 39 | 40 | 12 | 10 | |
Interest coverage | x | 0 | -34.0 | -47.0 | -3,859.0 | -50.0 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0 | 0 | 0 | 0 | 0 | |
Return on assets | % | -7.7 | -7.8 | -5.9 | -331.8 | -9.9 | |
Return on equity | % | -17.9 | -22.7 | -17.2 | -315.3 | -9.3 | |
Return on capital | % | -18.0 | -22.1 | -16.9 | -315.3 | -9.1 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
BACIL PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -3 | -4 | -4 | -40 | -1 | |
From Investments | Rs m | 3 | 4 | 5 | 38 | -1 | |
From Financial Activity | Rs m | -2 | -1 | -1 | 3 | 1 | |
Net Cashflow | Rs m | -2 | -0 | 1 | 1 | -2 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
COMP SEC: Bhavana Tak | YEAR OF INC: 1987 | BSE CODE: 524516 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare BACIL PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.